ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

DCE Board Approves Concept For 14-19 New Grants, Four New Contracts

November 4, 1988

HHS Carcinogen Guidelines Draft

June 13, 1980

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998